Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vets prescribing metronidazole against AMR guidelines, study finds
The study calls for adapted guidelines in future antimicrobial stewardship programmes.
Findings suggest it is being prescribed beyond its antimicrobial properties.

New research suggests that veterinary professionals have been prescribing metronidazole in contradiction to antimicrobial use guidelines.

In 42 per cent of cases, it was discovered that metronidazole was being used for non-antimicrobial targeted therapies. It was most often prescribed for acute diarrhoea, chronic diarrhoea or giardiasis.

This is despite advice that antimicrobials are very rarely appropriate for treating acute and chronic diarrhoea.

The findings were discovered as part of a survey of 138 veterinary professionals, primarily in the UK and working in primary care small animal practice. These professionals treated 332 cases (285 dogs and 47 cats) with metronidazole.

Those which had used metronidazole mostly justified its use by describing its anti-inflammatory or immunomodulatory properties.

Among the other justifications included suspected/confirmed anaerobic or susceptible bacterial infection, patients being systematically unwell or having severe disease, treating protozoal infections, and owner/practice expectations.

There were also 19 per cent of veterinary professionals using metronidazole based on prior positive outcomes, either in similar cases or the same patient.

This reliance on anecdotal reasoning corresponded with previous research, involving interviews with practitioners, with its frequency being linked to prescribing practices. This could lead to the inappropriate use of antimicrobials, therefore contributing to antimicrobial resistance.

Researchers are now calling for future stewardship programmes to learn from such behaviours. They say that these programmes should focus on advocating the use of non-prescription forms of medication.

The study also calls for adapted guidelines to tackle the inappropriate prescribing of metronidazole ad the development of educational resources that question specific rationales for metronidazole use.

Justin Ng, lead author of the study, said: “These insights are alarming given that such practices frequently deviate from current antimicrobial use guidelines, potentially contributing to ongoing challenges with antimicrobial resistance and adverse effects on gastrointestinal health.”

The full study can be found in the Journal of Small Animal Practice.

Image © luchschenF/Shutterstock.com

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.